Skip to main content
OpenTrials
Completed

NCT Number: NCT06161363

Description of Compliance With Hydroxychloroquine Treatment in Patients With Systemic Lupus Erythematosus

The project focuses on non-compliance in patients with systemic lupus erythematosus taking Plaquenil. More than half of patients with chronic illness are not or only poorly compliant with their treatment and lupus is one of them.

The investigators want to use an already validated existing questionnaire in English, the Morisky Medication Adherence Scale 8 (MMAS 8). These results will make it possible, after a multivariate study with reference to the gold standard which is hydroxychloroquinemia, to see which exact questions in the questionnaire can be used in general medicine practices in order to detect less or non-compliant patients as early as possible.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Lupus Erythematosus

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Toulouse Hospital

Toulouse, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age >18 years

  • Patient with systemic lupus erythematosus
  • Treatment with PLAQUENIL for > 6 months with dosage of hydroxychloroquinemia planned during the consultation.

Treatment and study plan

The Morisky Medication Adherence Scale

Other

The Morisky Medication Adherence Scale will be completed bu the patients

Primary outcomes

  1. Non-compliance with hydroxychloroquine treatment

    Time frame: Day 0

    to describe the non-compliance with hydroxychloroquine treatment with the Morisky Medication Adherence Scale

Sponsors and collaborators

Lead sponsor

University Hospital, Toulouse

Other

Registry information

Official study title

Description of Compliance With Hydroxychloroquine Treatment in Patients With Systemic Lupus Erythematosus in a Hospital Internal Medicine Consultation

Acronym: LES-HYDROXY

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Dec 7, 2023
Registry last updated
Dec 31, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.